Cart is empty EUROIMMUN ELISAs based on recombinant antigens p52 (IgM) and glycoprotein B (IgG) from cytomegalovirus (CMV) provided a higher rate of conclusive results in first-line testing of samples from pregnant women than lysate-based assays. A recombinant testing strategy could thus help…
Der Beitrag Recombinant ELISAs increase efficiency of CMV serodiagnosis in pregnant women erschien zuerst auf EUROIMMUNBlog.